Justin Wolfe
Co-Founder & Chief Scientific Officer Transcera Inc.
Seminars
Tuesday 27th October 2026
Harnessing Sphingolipid Biology for Targeted Degradation of Soluble & Membrane Proteins
5:00 pm
- Building on fundamental discoveries in sphingolipid biology, Transcera develop a new modality for extracellular protein degradation that harness native ceramide trafficking pathways
- Transcera’s degraders work across multiple cell types in tissues throughout the body and have extended half-life for durable target depletion,
- Transcera discovered new degraders for immune-mediated disease and is advancing towards a clinical candidate
